700 Crore Delhi Medical Scam: Did Vatsala Agrawal, Vinod Kumar Ranga, And Rajiv Rangila Make A Mockery Of The Entire Medical Machinery At National Capital?

₹700 Crore, Hundreds of Bank Accounts, and a Missing Paper Trail: Who Really Controlled Delhi’s Hospital Procurement, And Who Paid the Price?

When a government hospital in Delhi orders an X-ray machine, a box of surgical consumables or a sachet of oral rehydration salts, the transaction is supposed to be ordinary, almost invisible. A need is identified. A specification is written. Bidders compete. The lowest qualified bidder wins. A patient somewhere in a crowded ward gets a functioning machine or an available drug. That is the theory. The case now grinding through Delhi’s courts alleges that this ordinary chain was deliberately inverted.

It does not merely claim that the government paid too much. It claims that the contest itself was staged, that by the time the bids were opened the winner had already been selected, and that the public record was then allowed to look legitimate while money moved through channels that may never have been meant for public scrutiny. The question that hangs over every document, every missing file and every bank account is brutal and simple: who actually controlled the process, and why did so many people inside the system either fail to notice or choose not to stop it?

The allegations concern the procurement of medicines, surgical consumables and medical equipment for Delhi government hospitals through the Directorate General of Health Services and its Central Procurement Agency. According to the Anti-Corruption Branch, a network of public officials, a private pharmaceutical trader and supplier-linked entities allegedly manipulated the process from the tender-design stage itself. The alleged tools were tailor-made technical specifications, restrictive eligibility conditions, selected or fictitious firms, cartelisation, manipulation of the Government e-Marketplace process, rapid release of payments and the diversion of money through numerous bank accounts. Later the ACB told a court that important procurement files appeared to have been intentionally destroyed.

From complaint to FIR No. 7: how a quiet procurement process became a criminal case

The case did not begin with a dramatic raid on a warehouse. It began with complaints to the Delhi government’s Directorate of Vigilance about procurement by the Central Procurement Agency. In May 2026, Vigilance officials searched the CPA office and examined documents relating to X-ray machines, MRI machines, anaesthesia equipment, surgical equipment, medicines and other items. The matter was then handed to the Anti-Corruption Branch, which registered FIR No. 7 on 2 June 2026. A Delhi High Court order confirms the FIR number and the principal statutory provisions invoked.

Those provisions matter. They include Sections 7A, 13(1) and 13(2) of the Prevention of Corruption Act and Sections 61(2), 316(5), 318(4) and 238 of the Bharatiya Nyaya Sanhita. The combination is not accidental. The corruption-law sections point to undue advantage and criminal misconduct by public servants. The BNS sections point to conspiracy, criminal breach of trust, cheating and the causing of disappearance of evidence. The statutory choices therefore mirror the shape of the allegation itself. This is not framed as negligence or bureaucratic drift.

It is framed as a coordinated, deliberate scheme. Yet the first public descriptions of the matter were notably smaller than what followed. Early media reports spoke of a roughly ₹350-crore irregularity. The figure then grew: ₹600 crore, ₹640 crore, ₹700 crore and, in some prosecution-linked reporting, more than ₹750 crore. The ACB later settled on a broader figure of around ₹700 crore; prosecution submissions reported by ThePrint referred to more than ₹750 crore.

The alleged architecture: tenders built backwards

The most corrosive allegation is structural. According to the ACB, the process worked in reverse. Instead of an open tender discovering the best supplier, the alleged network first identified the preferred manufacturer or supplier and then structured the tender around it. The alleged sequence runs from manufacturer or supplier, to tailor-made specifications, to procurement officials, to the tender committee, to restrictive eligibility conditions, to selected firms, to the contract, to inflated invoices, to government payment, and finally to alleged diversion or kickbacks.

The ACB alleges that Rajiv Rangila worked with manufacturers to determine supply rates and arrange kickbacks, and that tender specifications were prepared to suit pre-selected companies before being routed to Dr Vinod Kumar Ranga. The ACB further alleges that the tender conditions imposed unusually high experience, turnover and performance requirements, with the explicit purpose of deterring genuine competitors.

A harder question follows immediately. How many tender committee members, finance officers and departmental reviewers saw these specifications and said nothing? The FIR reportedly alleges that officials were pressured or threatened with administrative consequences if they refused to approve allegedly tailor-made specifications. It also raises an uncomfortable counter-question that no one in the system appears eager to answer: why did no one complain earlier? Were there warnings that were ignored, or was the system designed so that dissent was costly and silence was safe? 

Competition as costume: the alleged proxy-firm network

The ACB and Vigilance allegations identify a set of private firms: F-Med Devices, Technocrats, Raj Shree, Ashi Surgical and Pharmaceuticals, and M Sahib and Sons Private Limited. Investigators allege that these companies were shown on paper as owned by other people while Rangila was the actual operator. Reports have described some of the alleged nominal owners as people in Rangila’s circle, including employees, servants and even tea vendors.

If that allegation is ultimately established in court, its implications are severe. A public tender depends on a simple assumption: that bidders are independent and are competing against one another. If several bidders are in fact one person operating under different names, then the price discovery that a tender is supposed to produce becomes theatre. The government believes it is choosing among rivals.

In truth, it may be choosing among costumes. The detail of a tea vendor as a nominal company owner is vivid, almost cinematic. But it remains an allegation reported from investigative sources. It is not a judicial finding. The crucial evidence will be bank accounts, GST records, incorporation documents, beneficial-ownership trails, communications, invoices and payment flows. Nominee ownership is not automatically criminal. It becomes criminal when used to defeat a competitive tender. Establishing that connection requires proof of control, not merely proof of proximity.

There is also a distinction that must be kept sharp. The chargesheet formally names only two private entities, F-Med Devices and M Sahib and Sons Private Limited. The other firms appear in the broader investigative narrative. Why the narrower formal list? Is the evidence against the other firms thinner? Is the investigation still incomplete? Or are further chargesheets planned? The public deserves to know whether the wider network is a prosecution theory or a prosecutable case. Until that distinction is clarified, the allegation of a sprawling proxy structure remains more dramatic than proven.

Rajiv Rangila: the alleged private centre of gravity

The ACB portrays Rajiv Kumar, also reported as Rajeev Kumar Rangila, as the key private-sector link. The prosecution’s theory places him between manufacturer, bidder and government official. The allegations against him include controlling allegedly fictitious or proxy companies, arranging their participation in tenders, working with manufacturers on specifications, fixing supply rates, arranging cash kickbacks, influencing officials, benefiting from payments to supplier firms and using restrictive eligibility requirements to exclude competitors. All of these remain allegations.

One of the most arresting claims comes from the prosecution’s account of Neeraj Chopra’s disclosure statement. According to ThePrint’s reporting of the court proceedings, Chopra allegedly referred to instructions or calls from a person called “Bhai,” whom investigators interpret as Rangila. The allegation, as reported, is that Ranga pressured officials to clear procurement files.

The price allegations — and the Health Department’s inconvenient counter-report

The most quotable allegations concern prices. The Indian Express reported alleged examples: a portable X-ray machine purchased at roughly ₹33 lakh against an estimated market cost of about ₹10 lakh; a linen bedsheet at about ₹450 against an alleged original price of about ₹150; and an ORS sachet at about ₹15 against an alleged market rate of about ₹2.50. The Tribune, reporting from the FIR, described alleged inflation of approximately 230 per cent for portable X-ray machines, 200 per cent for bedsheets, 340 per cent for C-arm radiological equipment and up to 500 per cent for ORS.

Take the X-ray figure alone. A difference of about ₹23 lakh on a single machine is, to a family struggling to afford private diagnostics, an almost incomprehensible sum. Multiply that across the number of machines, sheets and sachets implicated, and one begins to grasp why the allegations provoke anger. Public hospitals are where the poor go because they have no alternative. Every rupee alleged to have been inflated is a rupee not spent on a ward, a technician, a drug or a functioning diagnostic machine. The human impact is real even where the arithmetic remains contested.

There is a further uncomfortable question that no one appears eager to answer. The Health Department sits within the same government whose officials are accused. Whose interests does its report serve? Is it an independent technical assessment, or an institutional self-defence? Conversely, why have the ACB’s price comparisons, which are central to the public narrative, not received equal public scrutiny of their methodology?

GeM: a transparency platform allegedly used to obscure

The Government e-Marketplace was created to make procurement visible and comparable. The investigation alleges it was bent to the opposite purpose. According to the ACB’s case, some contracts continued to appear on the portal as “active” or “under process” even after orders had allegedly been awarded and payments released.

An example raised before the court concerned Red Mamba Force Private Limited. The prosecution alleged that the company was engaged to provide mobile digital chest X-ray screening under the TB Mukt Bharat Abhiyan even though the bid still appeared pending on GeM, and that Dr Ranga emailed hospitals and chest clinics asking them to permit the company’s radiographers to join. The associated bid files were allegedly missing from the CPA.

The example is instructive precisely because it involves tuberculosis screening, a public health programme whose beneficiaries are among the most vulnerable. If a contract was awarded outside the visible process for a service meant to find sick people, the issue is not only legal propriety. It is whether the programme’s reach was determined by merit or by access.

The prosecution allegation is specific, but it remains an allegation. We do not know what the defence says about this contract, whether the service was actually delivered, or whether the company is accused of any wrongdoing at all. The chargesheet’s named private entities do not include Red Mamba Force, which raises another question: is it cited as an illustration of process irregularity rather than as part of the alleged proxy network?

Portal manipulation also raises a systemic question that goes beyond the accused individuals. If a manual work order could be issued while GeM showed a bid as pending, then GeM’s controls did not prevent it. Who audits the gap between the portal and the physical file? If the answer is effectively “no one,” then the vulnerability exists regardless of the outcome of this particular case. A transparency platform that can be overridden without automatic red flags is not a transparency platform at all.

The missing files: negligence, theft or deliberate destruction?

On 19 August 2026 the ACB told the court that vital procurement files appeared to have been intentionally destroyed. The missing documents allegedly related to who prepared the tender documents, the technical specifications, the eligibility conditions, the tender terms, the technical and financial evaluation, the decision-making process and the final approvals. These are precisely the records that would show how a tender was constructed and by whom.

The ACB also alleged that Dr Ranga retained important procurement files in his personal custody, a claim the prosecution cited as one ground for opposing his bail.

This is the most disturbing element in the entire case, because documents are the memory of a bureaucracy. Without them, reconstruction of the chain of decision-making becomes dependent on witness statements, which are vulnerable to pressure, selective memory and self-interest. The disappearance of a file is also the one act that can both result from a crime and constitute one. The question that must be answered is therefore precise: was this administrative negligence, unauthorised removal, destruction, or deliberate evidence destruction? The legal consequences of each differ enormously. Negligence suggests a failing institution. Deliberate destruction suggests consciousness of guilt.

The money trail: hundreds of accounts and a question that still has no answer

The ACB told the court that payments moved through hundreds of bank accounts, including accounts of people apparently unrelated to the goods supplied, and that crores were later withdrawn in cash or transferred onwards. The chargesheet reportedly includes bank records and efforts to identify ultimate beneficiaries.

This allegation transforms the case from a procurement irregularity into a financial-diversion matter. Why would payments for medical goods land in accounts of people unconnected to the supply? Legitimate subcontracting is possible, but hundreds of accounts followed by cash withdrawals is the pattern investigators look for in layering. If this is borne out, it would also be among the strongest available evidence of a coordinated scheme rather than a merely bad process.

Yet the money trail is also where the prosecution’s case against at least one accused appears most contested. The defence of Dr Vatsala Aggarwal, according to her bail plea reported by The Indian Express, is that the chargesheet does not trace a single rupee of the alleged proceeds to her or any account connected with her. No illicit cash was recovered from her residence. Documents seized related to personal investments. 

Dr Vatsala Aggarwal: the approver, the accused, and an earlier institutional shadow

Aggarwal was arrested on 27 June 2026 and has been chargesheeted. She denies wrongdoing. Her bail defence reportedly argues that she merely approved proposals sent by the CPA, did not control the tender portal, that the CPA retained physical custody of the files, that no money has been traced to her, that no illicit cash was recovered from her residence, that documents seized related to personal investments, that the chargesheet does not identify any investment as disproportionate, that it contains no communication with Rangila, and that her dealings with Ranga were part of the formal administrative hierarchy.

These are not trivial points. The absence of a traced rupee is a serious gap in a corruption case. A prosecution that relies on a senior official’s approval as proof of conspiracy must explain why that approval was not simply the ordinary functioning of administration.

But the trial court has also pushed back. During arguments on 7 October 2026, Special Judge Vidya Prakash reportedly questioned how she could approve everything, including cases involving a single bidder, without applying her own mind. The bail matter was listed for 17 October 2026. This remains an unresolved factual and legal dispute. The judge’s question cuts both ways. If an approver may approve anything without scrutiny, what is the purpose of an approving authority? And if she did scrutinise, what exactly did she see?

She also challenged her arrest before the Delhi High Court, arguing that the arrest memo dated 27 June 2026 and subsequent remand orders violated constitutional safeguards and were mechanical. The High Court issued notice and sought the State’s response; it did not declare the arrest illegal. She obtained four weeks’ interim bail on medical grounds in August; the court later refused to extend it, held that her conditions could be treated in jail, and directed her to surrender.

Her earlier career casts a separate shadow that must be described with precision. Aggarwal served as director of the Delhi State Cancer Institute between 2023 and 2025. In 2024 the Delhi Vigilance Department began examining allegations about recruitment there concerning the appointment of Dr Minakshi Mann as Assistant Professor, with the complaint alleging that recruitment rules were altered to favour a particular candidate. 

In July 2026 Vigilance again sought an action-taken report. She became DGHS in August 2025. AAP leader Saurabh Bharadwaj later alleged that she was appointed despite the pending Vigilance inquiry and questioned why she was chosen for so sensitive a post. What can be said is narrower and more worrying: a Vigilance matter existed before her elevation, she was then appointed, and political opponents later questioned the decision. Whether the appointing authorities knew, considered it, or dismissed it is not fully clear from the public record. It is a question about institutional vetting, not a verdict on her.

Ranga and Chopra: the operational and financial links

Dr Vinod Kumar Ranga, the former Head of Office of the CPA, was the first major arrest, on 18 June 2026. The prosecution alleges that he received or handled tailor-made specifications, placed them before tender committees, exercised substantial influence, pressured officials, retained important files and acted as the governmental link to the private network. It also alleges that he and Aggarwal concentrated decision-making and bypassed intermediate officials. His defence reportedly argues that he followed established procedures and that decisions were taken with Aggarwal’s approval. His regular bail was rejected on 17 August 2026.

Ranga says he acted with Aggarwal’s approval; Aggarwal says she approved what the CPA sent. Each, in effect, points to the other as the source of authority. This circularity is not proof of guilt. But it exposes the central structural problem of the entire system: in a hierarchy where approvals are layered, responsibility can be diffused until it belongs to no one. The court will have to decide who, if anyone, designed the outcome and who merely processed it.

Neeraj Chopra, the former Deputy Controller of Accounts at the CPA, is accused on the financial-processing side. The Delhi government later sanctioned prosecution of all three officials. His role raises a different question from Ranga’s. Accounts officers are meant to be a check, scrutinising payments before release. If payments were released rapidly, as the ACB alleges, what did the check consist of? Was it ignored, overridden or complicit? The allegation of rapid release is serious precisely because the accounts function exists to slow down bad payments.

Flight, return, and the separate cases around Rangila

Rangila’s conduct forms a story of its own. After the ACB began seeking him, he allegedly stopped appearing before investigators. Searches were conducted in Delhi-NCR and Uttarakhand. He allegedly left India for the United States. The timing is controversial because he had obtained anticipatory bail on 30 June 2026 in a separate criminal matter registered at Laxmi Nagar Police Station shortly before leaving. A court later rejected his anticipatory bail in the medical procurement case, holding that custodial interrogation was necessary to investigate the money trail, missing documents and alleged conspiracy. He was reportedly declared a proclaimed offender. He returned from the United States and was arrested on or around 24–25 September 2026.

That sequence raises a pointed institutional question: how was a man sought by an anti-corruption agency able to leave the country? Was a lookout circular in place at the time of his departure? If it was not, the delay is an institutional lapse. If it was, the failure to stop him is more serious still. Either way, the ACB’s missing months of access to its principal alleged beneficiary meant that the investigation was impeded, a fact the prosecution itself used while opposing Ranga’s bail.

The chargesheet, the sanction, and the long shadow of pre-trial detention

In September 2026 the ACB filed a chargesheet of roughly 12,000 pages naming Aggarwal, Ranga, Chopra and two private entities, F-Med Devices and M Sahib and Sons Private Limited. It reportedly lists 84 prosecution witnesses and 123 documents. On 30 September 2026 the Delhi government granted sanction to prosecute the three public servants, a legal prerequisite for certain Prevention of Corruption Act prosecutions.

Consider the scale of those numbers. Eighty-four witnesses and 123 documents in a file of some 12,000 pages imply a trial that is likely to last years. For the accused, that means prolonged uncertainty. For the public, it means that any definitive answer on accountability may be distant. 

On 29 September 2026, Special Judge Vidya Prakash criticised the ACB’s documentation. One case diary appeared to contain material copied from the previous day’s diary. Two disclosure statements attributed to Rangila reportedly lacked dates. The court raised concerns about whether the investigation was being conducted properly, directed corrective measures, and observed that its earlier detailed observations had apparently not produced sufficient improvement in the Investigating Officer’s conduct.

The scandal produced administrative consequences. In August 2026 Delhi reportedly cancelled pending or incomplete CPA tenders and temporarily allowed government hospitals to procure medicines and other supplies directly. CPA functions were largely placed in abeyance except for essential drugs, while existing rate contracts continued subject to review. Early in the investigation the ACB was also reportedly examining the role of more than 100 doctors and officials associated with the procurement process. Forensic examination covered 29 hard drives seized from the CPA office along with CCTV and memory-card material.

And the people at the end of the chain? The patient waiting for an X-ray. The clinic that needs clean sheets. The child who needs rehydration salts. Whether or not every allegation is ultimately proved, a procurement system under suspension, with tenders cancelled and key officials in custody, creates delays and uncertainty. The cost of both the alleged corruption and the response to it falls on those with the fewest alternatives. The investigation has been loud about suspects and relatively quiet about whether supply to hospitals has been affected. That silence is itself a gap that deserves interrogation.

Every serious question in this case ends in a document or a rupee that has not yet been conclusively located. Who actually controlled the alleged supplier firms? Who supplied the technical specifications, and when? Who drafted and who approved the tenders? Who benefited financially? Where did the alleged cash ultimately go? Why were files missing, and were they negligently mislaid or deliberately destroyed?

Who were the alleged nominee owners, and did they have the means to run the companies attributed to them? Why did the Health Department find no evidence of overpricing when the FIR alleges inflation of up to 500 per cent? Why did a court find the investigating agency’s own records wanting? And why was a man sought by that agency able to leave the country?

What is established so far is narrower than the public narrative sometimes suggests. A Vigilance complaint existed. FIR No. 7 was registered on 2 June 2026. Three officials were arrested and Rangila was later arrested. A roughly 12,000-page chargesheet was filed naming two private entities. The Delhi government sanctioned prosecution. The ED opened a PMLA investigation and sought records. The court criticised aspects of the ACB’s investigation.

It is tempting to read this saga as a morality play with a settled cast: corrupt officials, a cunning trader, a scandalised public. The evidence as it stands does not permit that. It describes a very serious alleged public-procurement corruption network. The allegations of rigged tenders, proxy firms, restrictive eligibility, rapid payments, diverted money and missing records are the kind that, if proved, would justify severe consequences.